TAIHO PHARMA

We strive to
improve human
health and contribute
to a society enriched
by smiles

About Taiho

Becoming a truly global specialty pharma that meets the expectations of patients worldwide.

Our Business

Taiho Pharmaceutical creates innovative, highly valuable new drugs to support patients and the advancement of medicine, seeking to contribute to smiles and health for people all around the world.

News Release

October 20, 2017

Health Canada Grants Priority Review Status to TAS-102 (brand name in Japan: "LONSURF^Ⓡ") for Refractory Metastatic Colorectal Cancer
October 05, 2017

Taiho Pharmaceutical Releases Pitas Sore Throat Troche in Japan on October 5
A Sticker-type Troche to be Placed on the Roof of the Mouth That is Helpful in Business Meetings
October 04, 2017

Taiho Pharmaceutical to Participate in Japan Healthcare Venture Summit 2017
September 20, 2017

Taiho Pharmaceutical Concludes Option and License Agreement with Arcus Biosciences
September 07, 2017

Taiho Pharmaceutical Releases Harncare Granules Nationwide in Japan on Thursday, September 7ーan Effective Herbal Remedy to Improve Urinary Function by Warming up the Body from the Inside.